97. Ulcerative colitis Clinical trials / Disease details
Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01479660 (ClinicalTrials.gov) | March 2011 | 22/11/2011 | Role of Healthy Bacteria in Ulcerative Colitis | Probiotic for the Restoration of Intestinal Permeability and Reduction of Intestinal Inflammation in Active Ulcerative Colitis: A Double Blind Randomized Placebo Controlled Trial | Ulcerative Colitis | Other: Control;Drug: Probiotic | Postgraduate Institute of Medical Education and Research | Ministry of Science and Technology, India | Recruiting | 18 Years | 65 Years | Both | 100 | Phase 4 | India |